Wolff Olins has created the new brand identity for global healthcare company GSK (formerly GlaxoSmithKline), aiming to better express its focus on innovation. The agency was brought on board around 18 ...

Then his mother, Alia Hayes, got some bad news. The manufacturer, GSK, was going to stop manufacturing the brand-name ...

The biggest vaccine brand it has acquired in the deal is Bexsero, a new vaccine to prevent meningitis B, with a further candidate vaccine in late-stage development, MenABCWY. GSK intends to report ...

Latin America Cargo City is a single brand of Corporación ... Lacalle Pou “welcomed GSK's announcement of the opening of one of its three new regional vaccine distribution centers in Uruguay”.

New Delhi: GlaxoSmithKline's antibiotic drug Augmentin ... GSK's Augmentin has continued to maintain its top selling brand position. "Augmentin continues to be GSKs hallmark of quality and trust ...

GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits that alleged its discontinued heartburn drug Zantac caused cancer.

The decision is remarkable in that the HIV integrase inhibitor is one of ViiV’s most up-to-date products, only getting FDA approval under the Apretude brand ... GSK also said the new agreements ...

Created by Wolff Olins, the new identity sees the brand’s familiar cursive script replaced by a ... as can also be seen in the Kenvue identity and in GSK’s recent redesign (again by Wolff Olins). And ...

The new campus - which will sit next to GSK's existing site at Stevenage ... company's consumer healthcare division, which makes big-brand products including Sensodyne and Panadol.

When it does, it will probably prefer to issue more shares of stock, assuming it can't get one of its collaborators, like GSK, to fund further efforts. People who buy the stock today are thus ...

GSK is delivering consistent financial performance ... 14,000,15,000 people die every year in America. This is a brand-new vaccine with a cautious ACIP, but we are in their hands in terms of ...